MeSH tree: C19.344.421
Researchers at The University of Texas MD Anderson Cancer Center have found that a mitochondrial enzyme, GFER, creates an immunosuppressive environment within pancreatic tumors, leading to treatment resistance.
Dec 18, 2025
0
11
A research group at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has identified a candidate molecule that could improve current therapies against pancreatic cancer. The team designed the new molecule, ...
Dec 17, 2025
0
50
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a pancreatic cancer tumor ...
Dec 16, 2025
0
21
Normally, the immune system recognizes and eliminates abnormal cells. However, cancer cells can develop strategies to evade this control: they block defense mechanisms or send inhibitory signals. In this way, tumors can grow ...
Dec 12, 2025
0
23
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease's unique fibrotic microenvironment—a dense, ...
Dec 11, 2025
0
15
Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumor microenvironment (TME). This biological barrier surrounds the tumor, severely limiting the infiltration of chemotherapy agents and immune ...
Dec 11, 2025
0
10
Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine where they will metastasize, according to new findings from Columbia researchers. The work, published ...
Dec 8, 2025
0
24
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the disease has already spread throughout the body. The five-year survival rate for metastatic cases hovers around 2–3%, and median ...
Nov 25, 2025
0
192
Some tumors are almost impossible to treat. That's especially true for carcinomas, which don't behave like other malignancies. Some of these tumors act as shapeshifters and start to resemble cells from other organs of the ...
Nov 25, 2025
0
50
A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist treatment and points to potential new combination therapies to make treatments more effective.
Nov 24, 2025
0
15
